Edarbi 40 mg (Azilsartan Medoxomil (Azilsartan Medoxomil Potassium) TABLET) 40 MG

Edarbi 40 mg tablets contain azilsartan medoxomil, an angiotensin II receptor blocker (ARB) used to manage high blood pressure. This medication helps lower blood pressure by relaxing blood vessels, promoting cardiovascular health.

Strength

40 MG

Manufacturer / TM Owner

BAUSCH HEALTH, CANADA INC.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Edarbi 40 mg is primarily used for the treatment of hypertension, or high blood pressure. By blocking angiotensin II receptors, this medication helps blood vessels relax, reducing the strain on the heart and improving circulation. It is often prescribed as part of a comprehensive treatment plan that includes lifestyle changes.

Side Effects

Common effects of Edarbi 40 mg may include dizziness, headache, and fatigue. Some users may experience diarrhea or back pain. These effects are generally mild and temporary, but persistent or severe symptoms should be discussed with a healthcare provider.

Precautions & Warnings

Edarbi 40 mg should be used with caution in individuals with kidney or liver issues. It is important to follow the prescribed dosage and avoid sudden discontinuation. Pregnant women should consult their healthcare provider before using this medication.

Avoid Interactions

Edarbi 40 mg may interact with other medications, including diuretics, ACE inhibitors, and nonsteroidal anti-inflammatory drugs (NSAIDs). Alcohol consumption should be limited, as it can exacerbate the blood pressure-lowering effects. Always inform your healthcare provider about all medications you are taking.

Frequently Asked Questions

Edarbi 40 mg is used to treat high blood pressure by relaxing blood vessels and improving circulation.

Edarbi 40 mg is typically taken orally, with or without food, as directed by a healthcare provider.

Common side effects may include dizziness, headache, fatigue, diarrhea, and back pain.

Edarbi 40 mg may interact with other medications, so it is important to consult a healthcare provider before combining it with other treatments.

Pregnant women should consult their healthcare provider before using Edarbi 40 mg, as it may not be suitable during pregnancy.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.